Read More

SELLAS Life Sciences Reports Follow-Up Immune Response And Survival Data In Completed Phase 1 Study Of Galinpepimut-S Combined With Opdivo In Advanced Malignant Pleural Mesothelioma; Primary Endpoint Of Safety And Efficacy Met

- Primary Endpoint of Safety and Efficacy Met with Clinical Activity and Increased Survival Observed - - 70.3 Weeks Median Overall Survival for Patients Treated with Combination Therapy; Median Overall Survival in

SLS

Read More

GeoVax Labs And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed higher by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CATX